Skip to content

Efficacy of NIV Masks in COPD

Efficacy of NIV Masks in COPD Patients With Chronic Respiratory Failure: A Randomized Controlled Cross Over Pilot

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04947852
Enrollment
16
Registered
2021-07-01
Start date
2021-07-28
Completion date
2022-03-17
Last updated
2022-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD

Brief summary

A randomized controlled pilot study to compare the efficacy and tolerability of a two different NIV masks on carbon dioxide in participants with stable chronic obstructive pulmonary disease (COPD) with chronic type II respiratory failure.

Interventions

DEVICEInvestigation Mask

Oronasal bilevel continuous positive airway pressure mask fitted by the investigational staff

DEVICEComparator Mask

Oronasal bilevel continuous positive airway pressure mask fitted by the investigational staff

Sponsors

Fisher and Paykel Healthcare
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* A doctor's diagnosis of COPD * PtCO2 ≥45mmHg on transcutaneous monitor at baseline measure * Oxygen saturation measured by pulse oximetry (SpO2) ≥85% * Fits the study mask * Can tolerate the therapy

Exclusion criteria

* FEV1/FVC ≥70% * Body mass index \>35 * Hypercapnia considered to be primarily due to Obesity Hypoventilation syndrome and/or Obstructive Sleep Apnea * Any condition which makes NIV contra-indicated as per BTS guidelines based on clinical judgement

Design outcomes

Primary

MeasureTime frameDescription
Transcutaneous Carbon Dioxide60 minutesmmHg

Secondary

MeasureTime frameDescription
Oxygen Saturation60 minutesPercentage
Minute Ventilation60 minutesLitres
Heart Rate60 minutesBeats per minute
Respiratory Rate60 minutesBreaths per minute
Borg Dyspnoea Score60 Minutes1-6 Ranking, with 1 being best and 6 being worst

Countries

New Zealand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026